AVENUE THERAPEUTICS INC - COM NEW (ATXI) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2017 to Q3 2023

Type / Class
Equity / COM NEW
Symbol
ATXI on Nasdaq
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of AVENUE THERAPEUTICS INC - COM NEW (ATXI) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2023 Q3 0 $0 -$29,000 0
2023 Q2 25,000 $29,000 -$17,591 $1.16 1
2023 Q1 39,992 $46,591 $1.16 1
2022 Q3 0 $0 -$180,000 0
2022 Q2 669,617 $180,002 -$129,789 $0.27 15
2022 Q1 1,040,837 $503,004 -$1,270,728 $0.48 14
2021 Q4 2,361,854 $2,144,077 +$1,060,134 $0.91 15
2021 Q3 1,088,894 $1,624,198 -$256,613 $1.49 18
2021 Q2 1,148,320 $2,880,334 -$2,770,389 $2.50 24
2021 Q1 1,835,397 $11,140,868 -$1,317,927 $6.07 32
2020 Q4 2,054,996 $12,228,253 -$9,895,024 $5.95 33
2020 Q3 2,744,134 $29,721,805 +$1,424,781 $10.83 33
2020 Q2 2,612,551 $28,137,692 +$7,130,373 $10.77 36
2020 Q1 1,963,935 $17,557,000 +$3,193,295 $8.94 19
2019 Q4 1,568,930 $15,061,000 +$1,225,989 $9.60 13
2019 Q3 1,452,790 $8,657,000 +$531,694 $5.96 15
2019 Q2 1,363,573 $8,589,000 +$1,286,988 $6.30 12
2019 Q1 1,159,432 $5,506,000 +$2,237,119 $4.75 13
2018 Q4 688,200 $3,717,000 +$2,571,644 $5.40 7
2018 Q3 220,347 $624,000 -$273 $2.82 7
2018 Q2 220,363 $789,000 +$81,506 $3.57 7
2018 Q1 197,434 $890,000 +$261,868 $4.51 5
2017 Q4 142,439 $517,000 -$147,257 $3.63 5
2017 Q3 139,259 $771,000 +$609,203 $5.54 8
2017 Q2 28,590 $228,000 +$228,000 $8.11 2